| # | Drug | Count |
|---|---|---|
| 0 | DOXORUBICIN | 25 |
| 1 | FLUOROURACIL | 22 |
| 2 | FLUOROURACIL CREAM, 0.5% | 22 |
| 3 | PREDNISONE | 22 |
| 4 | ETOPOSIDE | 18 |
| 5 | CYCLOPHOSPHAMIDE | 15 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 15 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 15 |
| 8 | METHOTREXATE | 12 |
| 9 | METHOTREXATE SODIUM | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETOPOSIDE PHOSPHATE | 3 | 0.0018 |
| 1 | BUPROPION HYDROBROMIDE | 1 | 0.0017 |
| 2 | CARMUSTINE | 8 | 0.0017 |
| 3 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 4 | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | 1 | 0.0013 |
| 5 | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | 1 | 0.0011 |
| 6 | VINBLASTINE SULFATE | 2 | 0.0010 |
| 7 | RALTEGRAVIR | 5 | 0.0010 |
| 8 | ELRANATAMAB-BCMM | 1 | 0.0009 |
| 9 | PROCHLORPERAZINE EDISYLATE | 1 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Complement 5a Receptor Antagonist [EPC] | 4 | 0.0006 |
| 2 | Topoisomerase Inhibitor [EPC] | 18 | 0.0002 |
| 3 | CD30-directed Immunoconjugate [EPC] | 2 | 0.0002 |
| 4 | Penem Antibacterial [EPC] | 6 | 0.0002 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 35 | 0.0001 |
| 6 | Alkylating Drug [EPC] | 25 | 0.0001 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 10 | 0.0001 |
| 8 | Antimalarial [EPC] | 1 | 0.0001 |
| 9 | Antiprotozoal [EPC] | 1 | 0.0001 |